Dermapharm Holding SE (ETR:DMP)
Germany flag Germany · Delayed Price · Currency is EUR
38.30
-0.50 (-1.29%)
Sep 10, 2026, 5:35 PM CET

Dermapharm Holding SE Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
1,1811,1651,1811,1351,025942.91
Other Revenue
0.920.920.750.420.250.49
1,1821,1661,1821,1361,025943.4
Revenue Growth
0.40%-1.32%4.03%10.80%8.65%18.74%
Cost of Revenue
408.93412.65445.6446.6391.85349.87
Gross Profit
773.39753.25735.91689.18633.18593.54
Selling, General & Admin
306.58299.27287.43271.01190.56168.95
Other Operating Expenses
133.8136.55144.24136.24102.1982.99
Operating Expenses
524.38516.63513.84496.02350.45297.63
Operating Income
249.01236.62222.07193.16282.72295.91
Interest Expense
-45.41-48.67-58.41-54.97-12.34-8.84
Interest & Investment Income
5.355.6113.992.490.334.02
Earnings From Equity Investments
3.384.341.52-7.16-13.540.32
Currency Exchange Gain (Loss)
-4.81-4.811.4-1.950.372.28
Other Non Operating Income (Expenses)
26.571.75-0.96-16.63-1.12-0.83
EBT Excluding Unusual Items
234.1194.84179.61114.93256.43292.86
Merger & Restructuring Charges
------0.6
Impairment of Goodwill
-10.82-10.82-2.12--36.45-5.43
Gain (Loss) on Sale of Investments
---0-1.98-9.06
Gain (Loss) on Sale of Assets
0.280.280.632.963.131.38
Asset Writedown
-0.92-0.92-6.21-15.82-7.03-4.48
Other Unusual Items
-30--5.78--
Pretax Income
192.77183.51172.01106216.3292.98
Income Tax Expense
47.2352.1660.2745.4683.6884.07
Earnings From Continuing Operations
145.54131.35111.7460.53132.62208.9
Minority Interest in Earnings
0.991.062.051.831.620.68
Net Income
146.54132.41113.7962.37134.24209.58
Net Income to Common
146.54132.41113.7962.37134.24209.58
Net Income Growth
36.70%16.37%82.45%-53.54%-35.95%144.19%
Shares Outstanding (Basic)
535454545454
Shares Outstanding (Diluted)
535454545454
Shares Change
-1.68%-----
EPS (Basic)
2.772.462.111.162.493.89
EPS (Diluted)
2.772.462.111.162.493.89
EPS Growth
39.03%16.37%82.45%-53.54%-35.91%144.65%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
215.96187.03163.14177.88249.52189.17
Free Cash Flow Per Share
4.083.473.033.304.633.51
Dividend Per Share
0.8800.8800.9000.8801.0502.170
Dividend Growth
-2.22%-2.22%2.27%-16.19%-51.61%146.59%
Gross Margin
65.41%64.61%62.29%60.68%61.77%62.91%
Operating Margin
21.06%20.29%18.80%17.01%27.58%31.37%
Profit Margin
12.39%11.36%9.63%5.49%13.10%22.22%
Free Cash Flow Margin
18.27%16.04%13.81%15.66%24.34%20.05%
EBITDA
309.65264.74250.77220.31302.36312.36
EBITDA Margin
26.19%22.71%21.22%19.40%29.50%33.11%
D&A For EBITDA
60.6428.1228.727.1519.6416.45
EBIT
249.01236.62222.07193.16282.72295.91
EBIT Margin
21.06%20.29%18.80%17.01%27.58%31.37%
Effective Tax Rate
24.50%28.42%35.04%42.89%38.69%28.70%